Explorez tous les épisodes du podcast Joint Approach
| Titre | Date | Durée | |
|---|---|---|---|
| French Advances in Bacterial Phage Therapy for PJI's: Part 2 | 20 Oct 2026 | 00:25:21 | |
In the conclusion of this series on innovation in bacterial phage therapy for PJI's, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD continue the conversation with Professor Tristan Ferry, MD, PhD, Tiphaine Roussel-Gaillard, PharmD, PhD, and Thomas Briot, PharmD, PhD. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| French Advances in Bacterial Phage Therapy for PJI: Part 1 | 06 Oct 2026 | 00:29:50 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Professor Tristan Ferry, MD, PhD, Tiphaine Roussel-Gaillard, PharmD, PhD, and Thomas Briot, PharmD, PhD in part 1 of this 2-part conversation on innovation in bacterial phage therapy for PJI's. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Candidal PJI: Uncommon and Unforgettable, Part 2 | 22 Sep 2026 | 00:31:34 | |
In the conclusion of this series on candidal PJI's, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD discuss this challenging issue with Martin McNally, MD FRCSEd FRCS(Orth) and Aurélien Dinh, MD, PhD. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Candidal PJI's: Uncommon and Unforgettable, Part 1 | 08 Sep 2026 | 00:26:07 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with MartinMcNally, MD FRCSEd FRCS(Orth) and Aurélien Dinh, MD, PhD in part 1 of this 2-part conversation on candidal prosthetic joint infections. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Does the "5-second" Rule Apply to Dropped Medical Objects in the OR? | 18 Aug 2026 | 00:29:12 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD, and guests Sam Rosas, MD, PhD, David Weber, MD, MPH, and Bobby Warren, MPS, as they review the artcile entitled: "The "five-second" rule for dropped food: does it apply to dropped medical objects in the operating room? A randomized study of disinfection approaches for contaminated arthroplasty implants." Click here to access the abstract from the Journal: Infection Control and Hospital Epidemiology, March 26, 2026. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com, or visit Peptilogics.com. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Bugged and Baffled: A Case with Meredith Schade, Kelan Queenan, and Kevin Perry Part 2 | 04 Aug 2026 | 00:28:14 | |
In the conclusion of this challenging case discussion, Jessica Seidelman, MD and Johannes Plate, MD, PhD continue the conversation and the big reveal with Meredith Schade, MD, Kevin Perry, MD, and medical school student Kelan Queenan. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, genex®, and SYNICEMTM, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Bugged and Baffled: A Case with Meredith Schade, Kelan Queenan, and Kevin Perry- Part 1 | 21 Jul 2026 | 00:28:39 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In part 1 of this 2-part series, they discuss a challenging case with Meredith Schade, MD, Kevin Perry, MD, and medical school student Kelan Queenan. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, genex®, and SYNICEMTM, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Lysins: A Next Generation Treatment Option for PJI? Part 2 | 07 Jul 2026 | 00:26:25 | |
In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Gina Suh, MD, Ken Urish, MD, PhD, and Ray Schuch, PhD on the topic of innovation in treatment of PJI's with phage lysins. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, genex®, and SYNICEMTM, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Lysins: A Next Generation Treatment Option for PJI? Part 1 | 23 Jun 2026 | 00:27:25 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Gina Suh, MD, Ken Urish, MD, PhD, and Ray Schuch, PhD in part 1 of this 2-part conversation on the topic of innovation in treatment of PJI's with phage lysins. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, genex®, and SYNICEMTM, please click here | |||
| ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 2 | 09 Jun 2026 | 00:27:53 | |
In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with P. Maxwell Courtney, MD, Katherine Belden, MD, Poorani Sekar, MD on the topic of long term antibiotic usage at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com, or visit Peptilogics.com. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 1 | 19 May 2026 | 00:26:50 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with P. Maxwell Courtney, MD, Katherine Belden, MD, and Poorani Sekar, MD in part 1 of this 2-part conversation on the topic of long term antibiotic usage at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com, or visit Peptilogics.com. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| ICM Guidelines Discussion: "Is there a role for suppressive antibiotic treatment (SAT) only in patients with PJI?” Part 2 | 05 May 2026 | 00:26:56 | |
In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Michael Henry, MD and Daisuke Furukawa, MD on the topic of Suppressive Antibiotic Therapy (SAT) at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com. | |||
| ICM Guidelines Discussion: "Is there a role for Suppressive Antibiotic Treatment only in patients with PJI?” Part 1 | 21 Apr 2026 | 00:30:25 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Michael Henry, MD and Daisuke Furukawa, MD in part 1 of this 2-part conversation on the topic of Suppressive Antibiotic Therapy at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 2 | 07 Apr 2026 | 00:28:13 | |
In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Here are the ICM links: DOCUMENTS | ICMORTHO. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 1 | 24 Mar 2026 | 00:26:41 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD in part 1 of this 2-part conversation on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 2 | 10 Mar 2026 | 00:29:20 | |
In the final episode of this 2-part series, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation on Shoulder PJI definition evolution with Surena Namdari, MD, and Jason Hsu, MD. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com. | |||
| Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 1 | 17 Feb 2026 | 00:34:14 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they chat with Surena Namdari, MD, and Jason Hsu, MD in part 1 of this 2-part conversation on Shoulder PJI definition evolution. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com. | |||
| Bugged and Baffled: A Case with Meredith Schade and Stephanie Hawkins | 03 Feb 2026 | 00:27:58 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Meredith Schade, MD, and Stephanie Hawkins, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Dalbavancin/Oritavancin for treatment of PJI Part 3 | 20 Jan 2026 | 00:22:47 | |
In the conclusion of this series on long-acting antibiotics, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they wrap up the conversation with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the first episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproachor Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Dalbavancin/Oritavancin for treatment of PJI Part 2 | 06 Jan 2026 | 00:22:58 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they continue the in-depth discussion on long-lasting antibiotics with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the second episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode.For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Dalbavancin/Oritavancin for Treatment of PJI Part 1 | 16 Dec 2025 | 00:25:03 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they have an in-depth discussion about long-lasting antibiotics with Vance Fowler, MD, MHS, Thomas Holland, MD, and Thomas Lodise, PharmD, PhD in the first episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| The Psychosocial Impact of Orthopedic Joint Infections | 02 Dec 2025 | 00:34:08 | |
In this follow-up conversation from the International Consensus Meeting on Infection, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Allison Lastinger, MD, FACP, and Ran Schwarzkopf, MD about the question: “How can we capture the physical and psychological impact of orthopedic infections on patients?” FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Spinal Implant Infections Part 2 | 18 Nov 2025 | 00:34:21 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the discussion on spinal implant infections with Geno Tai, MD, and Francis Lovecchio, MD. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Spinal Implant Infections Part 1 | 04 Nov 2025 | 00:34:45 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss spinal implant infections with Gino Tai, MD, and Francis Lovecchio, MD in part 1 of this 2 part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Bugged and Baffled: A Case with Angela Hewlett and Curtis Hartman | 22 Oct 2025 | 00:35:24 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Angela Hewlett, MD, and Curtis Hartman, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Innovative Approaches to Bone and Joint Infections Part 3 | 07 Oct 2025 | 00:30:36 | |
Host Jessica Seidelman, MD and guests Kerry LaPlante, Pharm.D., FCCP, FIDSA, FIDP, and Julie Ann Justo, Pharm.D. conclude this 3-part series with discussions on pipeline innovations and adjunctive strategies for treating challenging prosthetic joint infections. Topics include local antibiotic administration, phage therapy, and immunotherapy. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com Listen to Breakpoints: The SIDP Podcast References: “Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection” PMID 34042388 “NDM-9 resistance to taniborbactam” PMID 36796395 “Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern” PMID 37394537 IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections https://www.idsociety.org/practice-guideline/amr-guidance/ “Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety” PMID 30648126 “Corynebacterium striatum Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin” PMID 36985124 “Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated with Dalbavancin: Case Report and Isolate Characterization” PMID 35510938 “Local antibiotic delivery via intra-articular catheter infusion for the treatment of periprosthetic joint infection: a systematic review” PMID 38691147 “A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model” PMID 26833157 | |||
| Innovative Approaches to Bone and Joint Infections Part 2 | 23 Sep 2025 | 00:25:04 | |
Host Jessica Seidelman, MD and guests Kerry LaPlante, Pharm.D., FCCP, FIDSA, FIDP, and Julie Ann Justo, Pharm.D. continue discussing long-acting antibiotics, systemic vs. oral antibiotics, and drug and dosing perspectives in episode 2 of this 3-part conversation. This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G with Gentamicin. CERAMENT G is an FDA-designated breakthrough device offering proven bone remodeling with reliable elution of broad-spectrum Gentamicin. CERAMENT G has a 96% success rate in eradication of infection in a single-stage for patients with fracture related infections and chronic osteomyelitis. To learn more and review CERAMENT G cases, visit their website at BONESUPPORT.com Listen to Breakpoints: The SIDP Podcast References: “Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection” PMID 34042388 “NDM-9 resistance to taniborbactam” PMID 36796395 “Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern” PMID 37394537 IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections https://www.idsociety.org/practice-guideline/amr-guidance/ “Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety” PMID 30648126 “Corynebacterium striatum Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin” PMID 36985124 “Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated with Dalbavancin: Case Report and Isolate Characterization” PMID 35510938 “Local antibiotic delivery via intra-articular catheter infusion for the treatment of periprosthetic joint infection: a systematic review” PMID 38691147 “A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model” PMID 26833157 FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Innovative Approaches to Bone and Joint Infections Part 1 | 09 Sep 2025 | 00:36:53 | |
Host Jessica Seidelman, MD has an in-depth discussion with Kerry LaPlante, Pharm.D., FCCP, FIDSA, FIDP, and Julie Ann Justo, Pharm.D. in the opening episode of this 3-part series. They discuss why PJI infections are so difficult to treat, and advances in antimicrobial agents in the pipeline. This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G with Gentamicin. CERAMENT G is an FDA-designated breakthrough device offering proven bone remodeling with reliable elution of broad-spectrum Gentamicin. CERAMENT G has a 96% success rate in eradication of infection in a single-stage for patients with fracture related infections and chronic osteomyelitis. To learn more and review CERAMENT G cases, visit their website at BONESUPPORT.com Listen to Breakpoints: The SIDP Podcast References: “Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection” PMID 34042388 “NDM-9 resistance to taniborbactam” PMID 36796395 “Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern” PMID 37394537 IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections “Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety” PMID 30648126 “Corynebacterium striatum Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin” PMID 36985124 “Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated with Dalbavancin: Case Report and Isolate Characterization” PMID 35510938 “Local antibiotic delivery via intra-articular catheter infusion for the treatment of periprosthetic joint infection: a systematic review” PMID 38691147 “A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model” PMID 26833157 FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Bugged and Baffled: Case 2 with Jenny Aronson | 19 Aug 2025 | 00:21:34 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss another challenging case with Jenny Aronson, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Bugged and Baffled: Case 1 with Jenny Aronson | 05 Aug 2025 | 00:27:44 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a the first of two challenging cases with Jenny Aronson, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Megaprostheses Part 2 | 22 Jul 2025 | 00:38:02 | |
Jessica Seidelman, MD, and Johannes Plate, MD. PhD conclude this discussion on the role of the Megaprosthesis in oncological indications with Juan Pretell, MD and Santiago Lozano-Calderon, MD, PhD. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Megaprostheses Part 1 | 08 Jul 2025 | 00:35:45 | |
Jessica Seidelman, MD, and Johannes Plate, MD, PhD host Juan Pretell, MD and Santiago Lozano-Calderon, MD, PhD as they discuss the role of the Megaprosthesis in oncological indications. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including results from the APEX clinical trials, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Bugged and Baffled: A Case with Alaina Ritter and Minu Abraham | 24 Jun 2025 | 00:26:54 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Alaina Ritter, MD, and Minu Abraham, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Bugged and Baffled: A Case with Jakrapun Pupaibool | 10 Jun 2025 | 00:24:52 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Jakrapun Pupaibool, MD, MS. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| PJI- Patient Perspective Part 2 | 20 May 2025 | 00:23:32 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they conclude the discussion, Patient Perspectives of PJI with William Jiranek, MD, and James Campbell, who is a registered nurse, a vascular access specialist, and a prosthetic joint infection survivor. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here | |||
| PJI - Patient Perspective Part 1 | 06 May 2025 | 00:22:28 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss Patient Perspectives of PJI with William Jiranek, MD, and James Campbell, who is a registered nurse, a vascular access specialist, and a prosthetic joint infection survivor. Stay tuned for the conclusion of this series. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Bugged and Baffled: A Case with Andy Miller | 15 Apr 2025 | 00:25:28 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this new Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Andy Miller, MD, Current President of MSIS, and Chief of Infectious Diseases at HSS. Spoiler alert- this case has just been published in JBJS and can be found at this link to the article. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Persistent and Challenging Orthopedic Infections: Biofilm Part 2 | 01 Apr 2025 | 00:21:14 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude this discussion onBiofilm with Ken Urish, MD, and Alexander Tatara, MD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Persistent and Challenging Orthopedic Infections: Biofilm Part 1 | 18 Mar 2025 | 00:25:33 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they have an engaging discussion on Biofilm with Ken Urish, MD, and Alexander Tatara, MD in part 1 of this 2 part series. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Shoulder PJI Part 2 | 04 Mar 2025 | 00:19:41 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude this discussion on shoulder periprosthetic joint infections with Mark Cullen, MD, Bryan Crook, MD and Christopher Klifto, MD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Shoulder PJI Part 1 | 18 Feb 2025 | 00:17:23 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss shoulder periprosthetic joint infections with Mark Cullen, MD, Bryan Crook, MD and Christopher Klifto, MD in part 1 of this 2 part series. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Diabetic Foot Infections Part 2 | 04 Feb 2025 | 00:35:33 | |
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude this discussion on diabetic foot infections with Kyle Wamelink, DPM and Marcos Schecter, MD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Diabetic Foot Infections Part 1 | 21 Jan 2025 | 00:27:43 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss diabetic foot infections with Kyle Wamelink, DPM and Marcos Schecter, MD in part 1 of this 2 part series. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Dental Prophylaxis for Patients Who Have Undergone Total Joint Arthroplasty | 07 Jan 2025 | 00:36:17 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss dental prophylaxis with Elie Berbari, MD, MBA and Charles Hannon, MD, MBA. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Fracture Related Infections Part 2 | 17 Dec 2024 | 00:31:32 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they conclude the conversation with Alaina Ritter, MD, and Malcolm DeBaun, MD about Fracture Related Infections. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Fracture Related Infections Part 1 | 03 Dec 2024 | 00:29:30 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they talk with Alaina Ritter, MD, and Malcolm DeBaun, MD in Part 1 of this discussion on Fracture Related Infections. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| One and Done or Two to Tango? 1 vs. 2-Stage Procedures for the Treatment of PJI Part 2 | 19 Nov 2024 | 00:34:17 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they conclude the conversation with Professor Fares Haddad, MBBS MD, MCh, FRCS FFSEMMD, and Thomas Fehring, MD about one-stage vs. two-stage revision with PJI. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| One and Done or Two to Tango? 1- vs. 2-Stage Procedures for the Treatment of PJI Part 1 | 05 Nov 2024 | 00:30:09 | |
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they talk with Professor Fares Haddad, MBBS MD, MCh, FRCS FFSEMMD, and Thomas Fehring, MD about one-stage vs. two-stage revision to treat PJI. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here . FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com | |||
| Plasma Microbial Cell-free DNA Next-generation Sequencing can be a Useful Diagnostic Tool in Patients with Osteoarticular Infections | 22 Oct 2024 | 00:20:31 | |
In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Francesco Petri, MD chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com
| |||
| Evaluating the Safety and Efficacy of Low-dose Chlorhexidine Gluconate Irrigation for Open Fracture Management | 15 Oct 2024 | 00:12:46 | |
In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Jaclyn Jankowski, DO chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. | |||